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Sequence variation plays a significant role in the pathogenesis and persistence of retroviral infections and is a major
obstacle in the development of vaccines as well as therapies against lethal diseases caused by retroviruses. Recombination
is one means by which sequence variation is generated. However, the basic molecular mechanisms of recombination are not
adequately understood. In the present study, a spleen necrosis virus (SNV) recombination system was used to ask whether
a known hot spot for mutation was also a hot spot for retroviral recombination. The system consisted of a pair of SNV vectors
expressing two drug-resistance genes, constructed so that recombinants could be selected by a double resistant phenotype.
Restriction enzyme site differences engineered into the vectors were used to map the location of recombination sites within
relatively small intervals (55 to 420 bp). The vectors were modified to create two pairs that differed only by the presence of
runs of identical nucleotides. The runs of identical nucleotides had been shown previously to be hot spots for frameshift
mutations during SNV reverse transcription. Each vector pair was introduced into DSDh helper cells by infection. Viruses
were harvested from doubly infected DSDh helper cells and used to infect D-17 target cells. Proviral sequences from 228 cell
clones were analyzed by polymerase chain reaction and restriction enzyme digestion. Significant differences in the patterns
of recombination were found between the two pairs of vectors. In particular, the frequency of recombination was higher than
expected in the interval immediately following the runs. For both pairs of vectors, the overall pattern of recombination was
nonrandom and one region was refractory toward recombination. © 1998 Academic Press
INTRODUCTION
Retroviruses replicate by an error-prone process
called reverse transcription in which their single-
stranded, positive-sense RNA genome is converted to a
proviral DNA intermediate (Dougherty and Temin, 1986;
Preston et al., 1988; Roberts et al., 1988; Temin, 1976).
Reverse transcriptase does not have a 39 to 59 exonu-
clease activity to ensure genomic accuracy during poly-
merization (Battula and Loeb, 1976; Morrison et al., 1991;
Roberts et al., 1988). Also, cellular repair systems are not
available to the virus during reverse transcription. Retro-
viruses further increase levels of genomic variation by
recombining their two RNA molecules during reverse
transcription (Hu and Temin, 1990a).
The primary nucleic acid sequence is known to affect
the type and rate of mutation during reverse transcrip-
tion. For example, runs of identical nucleotides are hot
spots for frameshift mutations in vivo (Burns and Temin,
1994; Pathak and Temin, 1990b), while direct repeat se-
quences are hot spots for deletion mutations (Pathak and
Temin, 1990a; Pulsinelli and Temin, 1991). Another exam-
ple is the GpA dinucleotide, which is a hot spot for G to
A transition mutations (Vartanian et al., 1991). Finally, the
context of the primary sequence may also affect muta-
tion rates for certain sequence motifs (Kunkel, 1990).
Beyond the level of the primary sequence, secondary
structure may also affect the process of mutation. Open
regions of viral RNA (regions not involved in stable base-
paired interactions) have been found to correlate with
variable regions of human immunodeficiency virus type 1
(HIV-1) (Le et al., 1989) and murine leukemia virus
(Parthasarathi et al., 1995). The open regions may have
been more susceptible to certain types of genetic dam-
age (such as breaks) that resulted in the observed
genomic variation (Le et al., 1989; Parthasarathi et al.,
1995).
In contrast to the mechanism of mutation, much less is
known about sequences and structures that promote
retroviral recombination. It has been reported that HIV-1
reverse transcriptase terminates synthesis within hairpin
stem structures in vitro (DeStefano et al., 1992a), sug-
gesting that closed regions may promote recombination.
Mikkelsen et al. (1996) identified a recombination hot
spot in a murine leukemia virus system. The hot spot
consisted of a 33-bp region containing RNA dimerization
and packaging sequences, a region known to contain
stem-loop structures required for encapsidation of the
viral RNA (Yang and Temin, 1994).
The hypothesis for the present study is that runs of
identical nucleotides serve as hot spots for retroviral
recombination. This hypothesis was justified by several
reports in the literature. First, runs of identical nucleo-
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tides had been identified previously as hot spots for
frameshift mutations, and recombination was a potential
mechanism for the frameshift mutations (Burns and Te-
min, 1994; Pathak and Temin, 1990b). Second, identical
nucleotide runs were shown to serve as pause and
termination sites for HIV-1 reverse transcriptase in vitro
(DeStefano et al., 1992a; Klarmann et al., 1993). Third,
pause sites were shown to enhance recombination by
HIV-1 reverse transcriptase in vitro (DeStefano et al.,
1992b).
To test the hypothesis, a spleen necrosis virus (SNV)-
based recombination system was used to study and
compare recombination events for pairs of retroviral vec-
tors that differed only in the presence of identical nucle-
otide runs. Recombination events were nonrandom for
both pairs of vectors. The insertion of the identical nu-




The SNV recombination system consisted of two ret-
roviral vectors (Fig. 1). Each of the two vectors contained
genes for neomycin and hygromycin resistance. How-
ever, each vector had one of the genes disabled by a
frameshift mutation so that recombinants could be se-
lected by a double resistant (doubler) phenotype. Two
pairs of vectors were constructed. One pair contained
runs of identical nucleotides between neo and hyg (Figs.
1a and 1b), and the other pair contained nonrun se-
quences at the same location (Fig. 1c). The run-contain-
ing inserts were similar to ones used by Burns and
Temin (1994). A control vector expressing functional neo
and hyg genes was constructed to test for expression of
hyg after insertion of the run-containing insert (Fig. 1d).
Four intervals, defined by the locations of frameshift
FIG. 1. Insert sequences and vectors. (a) Long synthetic oligonucleotides containing runs of identical bases (bold) were annealed to create inserts
1 and 2. Sticky ends are compatible with the restriction enzyme HindIII. The righthand HindIII site of insert 1 is nonfunctional due to an internal A
to G base change that was engineered into the oligonucleotide. Likewise, the lefthand HindIII site of insert 2 is nonfunctional due to a T to G base
change. Lowercase letters indicate base changes. Two pairs of vectors that either contain (b) or do not contain (c) runs of identical nucleotides are
shown. Each vector contains the neomycin and hygromycin resistance genes; however, one of the two genes in each vector is nonfunctional due to
a frameshift mutation (*). Vectors differ by restriction enzyme sites and are distinguished by open white or solid black boxes. Restriction enzymes are
as follows: N, NotI; C, ClaI; M, MluI; Nc, NcoI; H, HindIII; R, EcoRI; S, SacI; B, BamHI; Sm, SmaI; Bg, BglII. The gray-shaded boxes numbered 1 and
2 represent the oligonucleotide inserts containing runs of identical nucleotides. (d) Control vector. (e) Recombination intervals.
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mutations in neo and hyg and by restriction enzymes
HindIII, SmaI, and MluI, were studied (Fig. 1e). Intervals
were numbered one through four in the right to left
direction to correspond with first-strand synthesis by
reverse transcriptase.
Analysis of doubly resistant helper cell clones
Doubler helper cell clones were analyzed for proviral
structure, insert sequence, and virus production. Proviral
sequences were amplified by polymerase chain reaction
(PCR), cut with various restriction enzymes listed in Fig.
1, and analyzed by agarose gel electrophoresis. Compar-
ison of the patterns and sizes of the DNA fragments
revealed that all cell clones contained two different pro-
viral sequences as expected (1 white and 1 black; Fig. 1).
After confirming the integrity of the overall proviral
structures, the sequences of the inserts were then de-
termined. The individual proviruses were amplified by
PCR, and the products were directly sequenced. Se-
quence analysis revealed that all cell clones contained
the appropriate insert sequences.
Control experiment
Recombinant proviruses isolated from doubly resistant
target cell clones had to express functional neo and hyg
genes from the same retroviral genome. In order to rule
out the possibility that insertion of the run-containing
oligonucleotide affected splicing and expression of the
downstream hyg gene, a control vector was made which
contained insert 1 between functional neo and hyg
genes (Fig. 1d). Vector DNA was transfected into DSDh
helper cells, and hygromycin B was added to the medium
to select for cells harboring integrated vector sequences.
Virus was harvested from the transfected cells and was
used to infect D-17 target cells. In each experiment,
constructs were tested in parallel using a single drug
selection protocol, and the G418-resistant (G418r) and
hygromycin-resistant (Hygr) titers were compared. Re-
sults from these experiments showed that the G418r/Hygr
ratio was virtually identical for pJD216NeoHy (original
vector) and pJD216NeoHy1Insert (data not shown).
Therefore, insertion of the run-containing oligonucleotide
did not affect expression of the downstream hyg gene
from a vector with two functional drug resistance genes.
Recombination rate
The recombination rates were determined by harvest-
ing virus from doubly infected helper cell clones, infect-
ing D-17 target cells, determining viral titers, and calcu-
lating the rates (Fig. 2 and Materials and Methods). The
mean recombination rate for the run-containing cell
clones was 2.3 6 1.2%/kb per cycle with a range of 0.67
to 4.1%. For the nonrun cell clones the rate was 3.6 6
1.5%/kb per cycle, with a range of 1.6 to 6.2%.
An analysis of variance (ANOVA) was conducted using
a nested design and mixed procedure in the Statistical
Analysis System (SAS) Version 6.12. The analysis ac-
counted for variability within individual cell clones in the
run and nonrun groups. Comparison of the rates for the
run and nonrun groups revealed that the difference was
not statistically significant (P 5 0.1074). However, recom-
bination rates for the nonrun group generally tended to
be higher.
Location of recombination sites
Proviral sequences from doubly resistant D-17 cell
clones were amplified by PCR and analyzed by restric-
tion enzymes HindIII, MluI, and SmaI. The patterns of
bands observed on the agarose gels revealed the loca-
tions of the recombination events. A total of 86 run-
containing clones and 142 nonrun-containing clones
were analyzed. The number of recombination events
FIG. 2. Establishment of doubly infected cell clones and protocol for
one cycle of replication. In step 1, each vector DNA was transfected
separately into DSDh helper cells. Selection with the appropriate drug
was performed, and resistant cells were pooled separately. Virus was
harvested from hygromycin resistant (Hygr) step 1 cells and was used
to infect fresh DSDh helper cells (step 2a). Hygr cells were cloned and
were then infected with virus harvested from G418-resistant (G418r)
step 1 cells (step 2b). Finally, selection with hygromycin and G418 was
performed, and doubly resistant cell clones were isolated. Virus was
isolated from doubly infected helper cell clones and was used to infect
D-17 target cells in order to achieve one cycle of replication (step 3).
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observed within each interval was counted and com-
pared with the expected number. The expected number
reflects random recombination within the set length of
the interval (Table 1).
Frequencies were used in x2 analysis and Fisher’s
exact test to determine if differences were statistically
significant; Fisher’s test was used to analyze those in-
tervals with small frequencies (,20). The observed num-
ber of recombination events in the run-containing clones
was significantly higher than expected for interval 4 (P ,
0.005), while for the nonrun-containing clones the num-
ber was significantly higher than expected for interval 3
(P , 0.05). For both the run- and nonrun-containing
clones, the observed number of recombination events for
interval 1 was significantly lower than expected (P ,
0.001 and P , 0.005, respectively). Finally, the overall
pattern of recombination for both pairs of vectors was
nonrandom (P , 0.005) (Table 1).
DISCUSSION
In the studies described in this report, the rate of
recombination and the location of recombination was
determined for two pairs of SNV vectors that differed only
by the presence of runs of identical nucleotides. The
identical nucleotide runs had been shown previously to
be hot spots for frameshift mutation during SNV reverse
transcription (Burns and Temin, 1994; Pathak and Temin,
1990b). The pattern of recombination was significantly
altered between the two pairs of vectors.
Recombination rates were 2.3%/kb per cycle for run-
containing vectors and 3.6%/kb per cycle for the nonrun
vectors. Overall, the rates and variations were consistent
with previous reports on this system (Hu and Temin,
1990a,b, 1992; Jones et al., 1994a,b, 1993). It was not
surprising that rate differences were not statistically sig-
nificant. Previous studies have shown that despite some
rather drastic treatments and changes in the SNV vector
system, recombination rates were not altered. For exam-
ple, exposing the virions to gamma irradiation (Hu and
Temin, 1992), altering the location of the dimer linkage
site (Jones et al., 1993), and copackaging different sized
retroviral genomic RNAs (Jones et al., 1994b) did not
significantly alter the rate of recombination.
However, a surprising result was that the frequency of
recombination was significantly higher in interval 4 im-
mediately following the runs (Fig. 1, Table 1). A change in
the location of recombination was anticipated, but it was
expected that the change would be a higher frequency in
interval 3, which contained the runs (Fig. 1, Table 1).
Instead, the runs appeared to exert their influence on
recombination by acting at a distance (within 420 bp). It
is possible that the deletion of certain sequences was
responsible for the altered pattern of recombination. Dur-
ing construction, 89 bp of vector sequence was replaced
with a 55-bp oligonucleotide insert containing the runs.
Alternatively, RNA structure may explain the altered pat-
tern of recombination.
Another remarkable result was that recombination in
interval 1 (Fig. 1, Table 1) appeared to be inhibited.
Frequencies of recombination for this interval were lower
than expected (Table 1). Since this inhibitory effect was
observed for both pairs of vectors, it was not a run-
related phenomenon. However, the inhibitory effect was
more pronounced in the run-containing clones.
In conclusion, this study shows that while overall
recombination rates are fairly stable for a given retro-
virus system, relatively small sequence changes (less
than 100 bp) can dramatically alter the pattern of
recombination. Such information is extremely valuable
in understanding the basic molecular mechanisms of
recombination and in understanding the natural pat-
terns of retroviral variation observed worldwide. These
findings are also helpful in the design of retroviral-
based gene therapies. For example, the information
could be used to avoid unwanted gene rearrange-
ments in retroviral vectors used for therapies or vac-
cines. In the future, additional research should be
directed toward understanding higher order molecular
structures and their affects on the process of retroviral
recombination.
TABLE 1
Frequency of Recombination Events
No. (%) of recombination events in vector intervals
4 3 2 1 Total
Run
Observed 66 (77) 2 (2) 15 (17) 3 (4) 86 (100)
Expecteda 35 (41) 4 (5) 15 (17) 32 (37) 86 (100)
Nonrun
Observed 67 (47) 22 (16) 29 (20) 24 (17) 142 (100)
Expecteda 57 (40) 11 (8) 23 (16) 51 (36) 142 (100)
a Expected No. 5 (length of interval 4 total length of all intervals) (No. clones).
232 WOOLEY, BIRCHER, AND SMITH
MATERIALS AND METHODS
Construction of vectors
Long oligonucleotides (54-mers) were synthesized, 59-
phosphorylated with T4 polynucleotide kinase, and an-
nealed to create double-stranded DNA inserts 1 and 2
(Fig. 1a). The inserts were ligated between two HindIII
sites in pWH13 and pWH204 (Hu and Temin, 1990b) to
create vectors pDB13TC10 (white) and pDB204TC10
(black) (Fig. 1b). The 54-bp inserts were cloned between
neo and hyg, replacing 89 bp of sequence. As a result of
a base change engineered at the end of each insert, one
of two HindIII sites for each insert is nonfunctional after
cloning. The location of the functional HindIII site differed
for each vector in order to map recombination sites.
A pair of vectors was constructed that did not contain
runs of identical nucleotides for comparison of rates and
locations of recombination (Fig. 1c). One of two HindIII
sites in pWH13 and pWH204 (Hu and Temin, 1990b) was
disabled by partial digestion with HindIII and subsequent
fill-in and ligation to create vectors pWH13XH2 (white)
and pWH204XH1 (black) (Fig. 1c). The partial digestions
were performed by using 0.5 U of HindIII/mg of DNA at
37°C for 45 min. The digestion was stopped by addition
of EDTA to a final concentration of 15 mM and incubation
at 65°C for 20 min. Fill-in reactions were performed
using T4 DNA polymerase under manufacturer’s condi-
tions (New England Biolabs, Beverly, MA).
The control vector was constructed by cloning insert 1
(Fig. 1a) between two HindIII sites of a previously char-
acterized vector named pJD216NeoHy (Dougherty and
Temin, 1986).
Ligation mixtures were used to transform bacterial strain
NM522 of Escherichia coli. Small-scale DNA preparations
from individual bacterial colonies were screened by restric-
tion enzyme analysis and the final clones were selected by
DNA sequencing.
Cells
DSDh and D-17 cell lines were maintained in Temin-
modified Eagle’s medium (Biologos, Naperville, IL) (Te-
min, 1968) supplemented with 6% calf serum (EC6) at
37°C and 5% CO2. The DSDh helper cell line (No. CRL
2131, American Type Culture Collection, Rockville, MD)
expresses the gag-pol and env genes of SNV and was
derived from D-17 cells (Hu and Temin, 1990a). The D-17
cell line (No. CCL 183, American Type Culture Collection)
was derived from a dog osteosarcoma and is permissive
for SNV infection (Riggs et al., 1974). Selection with hy-
gromycin B (Calbiochem-Novabiochem Corp., La Jolla,
CA) was performed at 80 units/ml. Selection with G418
sulfate (a neomycin analog; Gibco BRL, Grand Island,
NY) was performed at 400 mg/ml. DSDh cell clones
harboring replication-competent proviruses were main-
tained in the constant presence of neutralizing anti-SNV
sera to prevent superinfection, as described by Dough-
erty and Temin (1986).
Transfection
Transfections were performed by the dimethyl sulfox-
ide/polybrene method (Kawai and Nishizawa, 1984).
Virus
All infections were performed using fresh virus stocks
and polybrene as described by Burns and Temin (1994).
Isolation of doubly infected helper cell clones
Doubly infected helper cell clones containing pairs of
vectors with and without runs of identical nucleotides
were established by infecting cells with one virus and
then superinfecting the same cells with the appropriate
second virus (Fig. 2).
Recombination rate
Viruses were harvested from doubly resistant helper
cell clones, diluted serially, and used to infect D-17 target
cells (Fig. 2, step 3). The infected D-17 cells were placed
under three separate drug selections in parallel (G418,
hygromycin B, and G418 plus hygromycin B). Each drug
selection was performed in replicates of two to six. Viral
titers were determined by counting the drug-resistant
colonies at the highest dilutions of virus. The recombi-
nation rates were calculated using the double resistant
titer and the lower of the two single resistant titers as
follows: Rate 5 [2(Doubler 4 Lower Singler)] 4 1.029
kb 4 1 cycle.
Cellular lysates
Cells from a confluent 100-mm tissue culture plate
were lysed, treated with proteinase K, boiled, and frozen
at 220°C as described by Burns and Temin (1994).
Polymerase chain reaction
Genomic DNAs from cell lysates were used as tem-
plates in PCR to amplify specifically the proviral DNA. For
analysis of the Doubler step 3 cell clones, one round of
PCR (two rounds, if needed) was performed using prim-
ers Neo1115 and 3288YH (Hu and Temin, 1992) in the first
round and primers 32 and 33 in the final round. Primer
sequences are as follows: (1) primer 32, 59-CAGC-
CGAACTGTTCGCCAGGC-39, and (2) primer 33, 59-CCT-
TGCGGTCCGAATGGGCCG-39.
For all first-round reactions, 50 ml of cellular lysate was
amplified in a 100-ml reaction. Prior to the first round,
reactions were heated at 94°C for 2 min and incubated
at 72°C during the addition of enzyme (hot start). Five
microliters was transferred into subsequent reactions,
and all rounds consisted of 30 cycles. Reaction condi-
tions varied for each set of primers according to the
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melting temperatures and distances between the prim-
ers. Vent DNA polymerase (New England Biolabs) or Taq
DNA polymerase (Gibco BRL, Gaithersburg, MD) was
used for all amplifications according to the manufactur-
er’s suggestions. The reaction mixture for round one was
supplemented with 4.0 mM MgSO4 when Vent polymer-
ase was used. All samples were amplified on a Perkin–
Elmer GeneAmp PCR System 9600.
DNA sequencing
Double-stranded plasmid DNA and PCR-amplified
DNA were used as templates for sequencing. For direct
sequencing of PCR-amplified DNA, three 100-ml reac-
tions were combined and concentrated to a volume of 40
to 75 ml. Primers from PCR were removed by purification
on CHROMA SPIN-400 columns (Clontech Laboratories,
Inc., Palo Alto, CA). Sequencing was performed using the
Sequenase DNA Sequencing Kit (United States Biochem-
ical Corp., Cleveland, OH), and reactions were analyzed
on a denaturing 6% polyacrylamide gel.
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